Evidence map›Paper›PMID 32819370›Full record

ArticleCell communication and signaling : CCS2020

SRSF1 regulates exosome microRNA enrichment in human cancer cells.

Yi-Fan Xu, Xiaohui Xu, Amy Gin, Jean D Nshimiyimana, Blaine H M Mooers, Massimo Caputi, Bethany N Hannafon, Wei-Qun Ding

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Experimental and therapeutic medicine · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Exosome miRNA sorting controlled by RNA-binding protein-motif interactions.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yi-Fan XuDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 940 Stanton L. Young Blvd., BMSB 401A, Oklahoma City, OK, 73104, USA.
Xiaohui XuDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 940 Stanton L. Young Blvd., BMSB 401A, Oklahoma City, OK, 73104, USA.
Amy GinDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 940 Stanton L. Young Blvd., BMSB 401A, Oklahoma City, OK, 73104, USA.
Jean D NshimiyimanaDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 940 Stanton L. Young Blvd., BMSB 401A, Oklahoma City, OK, 73104, USA.
Blaine H M MooersDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Massimo CaputiCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 33431, USA.
Bethany N HannafonDepartment of Obstetrics and Gynecology, Section of Gynecologic Oncology, Stephenson Cancer Center, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73103, USA.
Wei-Qun DingDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, 940 Stanton L. Young Blvd., BMSB 401A, Oklahoma City, OK, 73104, USA. weiqun-ding@ouhsc.edu.ORCID 0000-0001-7358-3700
University of Oklahoma Health Sciences Center · USFlorida Atlantic University · USSoochow University · CN

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Valerie Williams · 2013 to 2026
$68.2M
Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DARRIN R. AKINS · 2012 to 2026
$60.2M
Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michael S. Businelle · 2018 to 2026
$27.1M
Structure-Function Studies of MsvR, a Methanogen-Specific Transcriptional RegulaP20GM103640 · NIGMS · UNIVERSITY OF OKLAHOMA · PI MOOERS, BLAINE H. M. · 2012 to 2021
$20.4M
The initiation of exosome microRNA signaling in pancreatic cancer cellsR03CA235208 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DING, WEI-QUN · 2019 to 2020
$145k
NCI NIH HHS P30 CA225520NCI NIH HHS R03 CA235208NIGMS NIH HHS P20 GM103447NIGMS NIH HHS P20 GM103640NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

backgroundExosomes are extracellular vesicles containing a variety of biological molecules including microRNAs (miRNAs). We have recently demonstrated that certain miRNA species are selectively and highly enriched in pancreatic cancer exosomes with miR-1246 being the most abundant. Exosome miRNAs have been shown to mediate intercellular communication in the tumor microenvironment and promote cancer progression. Therefore, understanding how exosomes selectively enrich specific miRNAs to initiate exosome miRNA signaling in cancer cells is critical to advancing cancer exosome biology.

resultsThe aim of this study was to identify RNA binding proteins responsible for selective enrichment of exosome miRNAs in cancer cells. A biotin-labeled miR-1246 probe was used to capture RNA binding proteins (RBPs) from PANC-1 cells. Among the RBPs identified through proteomic analysis, SRSF1, EIF3B and TIA1 were highly associated with the miR-1246 probe. RNA immunoprecipitation (RIP) and electrophoretic mobility shift assay (EMSA) confirmed the binding of SRSF1 to miR-1246. Lentivirus shRNA knockdown of SRSF1 in pancreatic cancer cells selectively reduced exosome miRNA enrichment whereas GFP-SRSF1 overexpression enhanced the enrichment as analyzed by next generation small RNA sequencing and qRT-PCR. miRNA sequence motif analysis identified a common motif shared by 36/45 of SRSF1-associated exosome miRNAs. EMSA confirmed that shared motif decoys inhibit the binding of SRSF1 to the miR-1246 sequence.

conclusionsWe conclude that SRSF1 mediates selective exosome miRNA enrichment in pancreatic cancer cells by binding to a commonly shared miRNA sequence motif. Video Abstract.

Indexed as

Base SequenceCell Line, TumorExosomesGene Expression RegulationHumansMicroRNAsNeoplasmsNucleotide MotifsProtein BindingReproducibility of ResultsSerine-Arginine Splicing FactorsMicroRNAsSerine-Arginine Splicing FactorsSRSF1 protein, humanExosomemiR-1246miRNAPancreatic cancerSRSF1

Identifiers

PMID32819370
PMCPMC7439691
OpenAlexW3054015426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.